Good clinical response to methotrexate treatment in a patient with fibroblastic rheumatism
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
30/10/2013
30/10/2013
02/08/2013
|
| Resumo |
Fibroblastic rheumatism (FR) is a rare disease first described by Chaouat (in Rev Rhum Mal Osteoartic 47: 345-351, 1980) and is characterized by a combination of rheumatologic and dermatological manifestations. Rheumatologic features are symmetrical polyarthralgias with joint stiffness, associated with cutaneous nodules and sclerodactyly. Histology shows an increased number of fibroblasts and a marked dermal fibrosis. A large number of treatments have been tried, but all of them have shown an unpredictable effect on FR. We report a Brazilian case of FR showing a good clinical response to methotrexate treatment. This drug may be considered an effective treatment in FR. Federico Foundation Federico Foundation CNPq CNPq [300665/2009-1] |
| Identificador |
RHEUMATOLOGY INTERNATIONAL, HEIDELBERG, v. 32, n. 6, supl. 4, Part 1-2, pp. 1789-1791, JUN, 2012 0172-8172 http://www.producao.usp.br/handle/BDPI/36921 10.1007/s00296-010-1433-2 |
| Idioma(s) |
eng |
| Publicador |
SPRINGER HEIDELBERG HEIDELBERG |
| Relação |
RHEUMATOLOGY INTERNATIONAL |
| Direitos |
closedAccess Copyright SPRINGER HEIDELBERG |
| Palavras-Chave | #FIBROBLASTIC RHEUMATISM #CUTANEOUS NODULOSIS #FIBROSIS #PEYRONIE'S DISEASE #RHEUMATOLOGY |
| Tipo |
article original article publishedVersion |
